Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/29004
Title: Editorial: The Immunology of Adverse Drug Reactions.
Austin Authors: Illing, Patricia T;Mifsud, Nicole A;Ardern-Jones, Michael R;Trubiano, Jason 
Affiliation: Infection and Immunity Program, Monash Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC, Australia..
Centre for Antibiotic Allergy and Research
Clinical Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom..
Department of Dermatology, University Hospitals Southampton NHS Foundation Trust, Southampton, United Kingdom..
Infectious Diseases
Issue Date: 18-Feb-2022
Date: 2022
Publication information: Frontiers in Immunology 2022; 13: 863414
URI: https://ahro.austin.org.au/austinjspui/handle/1/29004
DOI: 10.3389/fimmu.2022.863414
ORCID: 0000-0002-5111-6367
Journal: Frontiers in immunology
PubMed URL: 35251055
PubMed URL: https://pubmed.ncbi.nlm.nih.gov/35251055/
Type: Journal Article
Subjects: MRGPRX2
T cells
adverse drug reaction
drug allergy
drug hypersensitivity
human leukocyte antigen
Appears in Collections:Journal articles

Show full item record

Page view(s)

28
checked on Oct 27, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.